期刊文献+

66例老年女性乳腺癌患者的临床分析 被引量:2

Clinical Research of the 66 Elderly Female Breast Cancer Patients
下载PDF
导出
摘要 目的:探讨老年女性乳腺癌的临床特征及预后因素。方法:回顾性分析66例70岁以上年女性乳腺癌患者的临床资料及治疗效果。结果:全组患者1年生存率为100%,3年生存率为82.2%,5年生存率为73.0%。单因素分析显示,肿瘤分期、淋巴结转移、病理分子分型、有无手术和内分泌治疗是影响老年乳腺癌患者预后的主要因素。Cox多因素分析显示,肿瘤分期、淋巴结转移和有无手术是影响预后的独立因素。结论:老年女性乳腺癌具有独特的生物学特点,ER、PR阳性表达率高,肿瘤分期及淋巴结转移是影响预后的主要因素,所以早发现、早治疗可提高生存率。病理类型主要为浸润性导管癌,治疗应选择以手术为主的综合治疗,其中内分泌治疗占重要地位。 Objective:To evaluate the clinical features and prognostic factors of elderly female breast cancer pa-tients. Methods:The clinical data and treatment effects of 66 cases of female breast cancer patients over the age of 70 years were retrospectively analysized. Results:In the whole group,the 1-year survival rate was 100% ;3-year survival rate was 82. 2% ;and the 5-year survival rate was 73% . Univariate analysis showed that the factors,tumor pathology staging,lymph node metastasis,molecular typing,surgery and hormonal treatment ,were the keys to influencing the prognosis of elderly patients with breast cancer. Cox multivariate analysis showed that staging,lymph node metastases and surgery were independent prognostic factors. Conclusions:Elderly women Patients with breast cancer involve u-nique biological characteristics. They have higher frequency of ER and PR positivity,tumor stage and lymph node me-tastasis,which are the main prognostic factors. Therefore,early detection and early treatment can improve survival. The main pathological type is primary invasive ductal carcinoma. Surgery should be chosen as the main method of combined treatment,in which hormone therapy plays an important role.
机构地区 山西省肿瘤医院
出处 《山西职工医学院学报》 CAS 2015年第5期11-14,共4页 Journal of Shanxi Medical College for Continuing Education
关键词 乳腺癌 老年女性 临床特征 预后因素 breast cancer elderly women clinical features prognostic factors
  • 相关文献

参考文献13

  • 1Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2007 [J ]. CA Cancer J Clin,2007,57( 1 ) : 43-66.
  • 2Jatoi I, Chen BE, Anderson WF,et al. Breast Cancer Mortality Trends in the United States according to Estrogen Receptor Status and at Di- agnosis [ J ]. J Clin Onco1,2007,25 ( 13 ) : 1683-1690.
  • 3Jemal A, Siegel R, Ward E,et al. Cancer Statistics, 2009 [ J ]. CA Cancer J C1in,2009,59(4) :225-249.
  • 4王中华,徐兵河.129例30岁以下女性乳腺癌的临床特点及预后分析[J].中华肿瘤杂志,2005,27(2):111-113. 被引量:40
  • 5王周权.老年乳腺癌140例临床病理特点及预后分析[J].陕西医学杂志,2009,38(11):1504-1506. 被引量:22
  • 6陈嘉健,柳光宇.浸润性乳腺癌分子分型与辅助化疗方案选择[J].中国实用外科杂志,2011,31(10):931-934. 被引量:8
  • 7何依珊,李孟圈.70岁以上乳腺癌不同分子亚型与淋巴结转移的关系[J].中国老年学杂志,2013,33(1):181-182. 被引量:6
  • 8Bickell NA, McEvoy MD. Physicians' Reasons for Failing to Deliver Effective Breast Cancer Care. A Framework for Underuse[ J]. Med Care ,2003,41:442.
  • 9Kimmick G, Kornblith A, Mandelblatt J, et al. A Randomized Con- trolled Trial of an Educational Program to Improve Accl'ual of Older Persons to Cancer Treatment Protocols: CALGB 360001 [ J ]. J Clin Oncol,2004,22(14) : 739S.
  • 10N. A. de Glas,M. Kiderlen, E. Bastiaannet, et al. Postoperative Complications and Survival of Elderly Breast Cancer Patients : a Fo- cus Study Analysis [ J ]. Breast Cancer Research and Treatment, 2013, 138(2) : 561-569.

二级参考文献50

  • 1应红艳,白春梅,管梅,陈书长.老年乳腺癌患者的临床病理特点及治疗影响因素[J].中国医学科学院学报,2010,32(4):398-402. 被引量:25
  • 2胡国清,胡长耀.30岁以下女性乳腺癌预后因素探讨(附52例临床分析)[J].同济医科大学学报,1994,23(3):244-244. 被引量:1
  • 3王中华,徐兵河.129例30岁以下女性乳腺癌的临床特点及预后分析[J].中华肿瘤杂志,2005,27(2):111-113. 被引量:40
  • 4Carey LA, Perou CM, Livasy CA, et al. Race, Breast cancer subtypes and survival in the Carolina breast cancer study [J]. JAMA, 2006,295(21) : 2492-2502.
  • 5Phipps AI, Chlebowski RT, Prentice R, et al. Body size, physical activity, and risk of triple-negative and estrogen receptor-posi- tive breast cancer[J]. Cancer Epidemiol Biomarkers Prey,2011 , 20(3):454-463.
  • 6Phipps AI, Buist DS, Malone KE, et al. Reproductive history and risk of three breast cancer subtypes defined by three biomarkers [J]. Cancer Causes Control, 2011,22(3):399-405.
  • 7Albain KS, Barlow WE, Shak S,et al. Breast Cancer Intergroup of North America. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial [J]. Lancet Oncol,2010,11(1):55-65.
  • 8Nguyen PL, Taghian AG, Katz MS, et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy [J]. J Clin Oncol, 2008,26(14): 2373-2378.
  • 9Goldhirsch A, Ingle JN, Gelber RD,et al. Thresholds for thera- pies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009 [J ]. Ann On- col, 2009,20(8):1319-1329.
  • 10Goldhirsch A, Wood WC, Coates AS, et al. Strategies for sub- types-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 [J ]. Ann Oncol,2011, 22(8): 1736-1747.

共引文献72

同被引文献8

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部